Delivery Order SPE2DB20D3103-SPE2DB24FM4J7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,989.50 firm-fixed-price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 31, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,659.26, is a Delivery Order that covers the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 20, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,771.93, is for the supply of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract has an ultimate completion date of December 1, 2023 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,795.38, is for the delivery of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 30, 2024. This contract award is not designated as a set-aside....
- This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, has received this $25,574.92 firm fixed price delivery order contract from the DLA. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC)...
- This federal contract award, valued at $235,947.15, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for the company to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceuticals and medical supplies. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,274.88, for the supply of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The contract has an Ultimate Completion Date of April 1, 2025 and was awarded on March 31, 2025. This award is not a set-aside contract....
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $5,287.68 and awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM4J7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,733.00 firm fixed price delivery order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 1/29/24 |